莫西沙星序贯疗法根除Hp感染效果观察

莫西沙星序贯疗法根除Hp感染效果观察
李康;朱观宇;张晖;黄卫
【期刊名称】《检验医学与临床》
【年(卷),期】2017(014)0Z1
【摘要】目的研究由埃索美拉唑联合莫西沙星、阿莫西林、克拉霉素组成的序贯疗法根除幽门螺杆菌(Hp) 的疗效.方法将92例Hp阳性的患者随机分为两组.治疗组采用前5 d应用埃索美拉唑20 mg加阿莫西林1 000 mg,2次/d,后5天使用埃索美拉唑20 mg加克拉霉素500 mg,2次/d;莫西沙星400 mg qd.对照组采用埃索美拉唑20 mg加阿莫西林1 000 mg加克拉霉素500 mg,2次/d共7d.4周后复查内镜和呼气试验.结果治疗组幽门螺杆菌根除率93.6%,对照组82.2%,两组差异有统计学意义(P<0.05);治疗组和对照组不良反应发生率差异无统计学意义.结论含莫西沙星的序贯疗法Hp根除率高,副反应低.%Objective To evaluate the efficacy of ten days sequential therapy consisted of
Moxifloxacin,amoxicillin,Clarithromycin and Esomeprazole in Helicobacter pylori infection.Methods Ninty-two patients with H.pylori-infected were randomly divided into two groups.Treatment group received 5 days esomeprazole 20mg and amoxicillin 1000mg,twice a day;The follow-up 5 days received esomeprazole 20mg,clarithromycin 500mg,twice a day and moxifloxacin 400mg one time a day.Control group received 7 days therapy consisted of esomeprazole 20mg,amoxicillin 1000mg and clarithromycin 500mg twice a day.All patients were observed by 13-C urea breath test and endoscopy in fourweeks after treatment.Results The eradication rates of
the treatment group and the control group were 93.6% and 82.2% respectively(P<0.05);There were no significant differences in the adverse event rates of two groups.Conclusion Moxifloxacin-based sequential therapy is effective and lower side-effects in eradication of Helicobacter pylori infection.
【总页数】2页(P44-45)
【作者】李康;朱观宇;张晖;黄卫
【作者单位】广东省广州市番禺区何贤纪念医院消化内科,广东广州 511400;广东省广州市番禺区何贤纪念医院消化内科,广东广州 511400;广东省广州市番禺区何贤纪念医院消化内科,广东广州 511400;广州市暨南大学附属第一医院消化内科,广东广州 511406
【正文语种】中文
【相关文献】
1.莫西沙星为基础的三联疗法根除Hp感染的疗效观察 [J], 孙丽丽;郝明华;孙振波
2.加替沙星10日序贯疗法根除消化性溃疡Hp感染疗效观察 [J], 李康;刘旭明
3.序贯疗法在Hp感染性胃溃疡中的应用及吸烟对Hp根除的影响 [J], 成雁文
4.莫西沙星为基础的三联疗法根除常规治疗失败的Hp感染疗效观察 [J], 窦文琴
5.莫西沙星为基础的三联疗法根除Hp感染的疗效观察 [J], 孙丽丽; 郝明华; 孙振波
因版权原因，仅展示原文概要，查看原文内容请购买。